Publicacions en col·laboració amb investigadors/ores de Instituto de Investigación Sanitaria de Navarra (36)

2026

  1. NADPH oxidase 5 promotes adhesion and infiltration of immune cells in the brain. Implications in ischemic stroke

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1872, Núm. 4

  2. NADPH oxidase 5 promotes adhesion and infiltration of immune cells in the brain. Implications in ischemic stroke

    Biochimica et Biophysica Acta - Molecular Basis of Disease

2025

  1. Astrocytes as Metabolic Sensors Orchestrating Energy-Driven Brain Vulnerability in Alzheimer's Disease

    Journal of Neurochemistry, Vol. 169, Núm. 10

  2. Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer's disease

    Brain, Behavior, and Immunity, Vol. 129, pp. 223-243

2024

  1. Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis

    Science Advances , Vol. 10, Núm. 42

  2. Essential Role of Astrocytes in Learning and Memory

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  3. The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

    Nature Communications , Vol. 15, Núm. 1

  4. Zein nanoparticles extend lifespan in C. elegans and SAMP8 mice

    International Journal of Pharmaceutics, Vol. 666

2023

  1. Editorial: New insights into the role of neuroinflammation and glial cells in the development of neurological disorders

    Frontiers in Cellular Neuroscience

  2. JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology

    ACS Chemical Neuroscience

  3. JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding

    ACS Chemical Neuroscience, Vol. 14, Núm. 11, pp. 2074-2088

  4. Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance

    International Journal of Molecular Sciences, Vol. 24, Núm. 5

  5. Trimethylamine N-Oxide as a Mediator Linking Peripheral to Central Inflammation: An In Vitro Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

2022

  1. Brain Metabolic Alterations in Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  2. Dysbiosis and Alzheimer’s Disease: Cause or Treatment Opportunity?

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 2, pp. 377-387

  3. The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  4. Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model

    Mechanisms of Ageing and Development, Vol. 204

2021

  1. 5-HT7 receptors in Alzheimer's disease

    Neurochemistry International, Vol. 150

  2. Biomarcadores en la enfermedad de Alzheimer

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 39-50

  3. Biomarkers in Alzheimer's disease

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 27-37